Method for differentiating a XIII factor and fibrinogen deficiency states by means of thrombelastographic engineering

Details for Australian Patent Application No. 2006212471 (hide)

Owner CSL Behring GmbH

Inventors Wrabetz, Erhardt; Korte, Wolfgang; Metzner, Hubert

Agent Watermark

Pub. Number AU-B-2006212471

PCT Pub. Number WO2006/084648

Priority 10 2005 005 824.8 08.02.05 DE

Filing date 6 February 2006

Wipo publication date 17 August 2006

Acceptance publication date 24 February 2011

International Classifications

G01N 33/86 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving blood coagulating time

C12Q 1/56 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen

G01N 33/49 (2006.01) Investigating or analysing materials by specific methods not covered by groups - blood

Event Publications

27 September 2007 PCT application entered the National Phase

  PCT publication WO2006/084648 Priority application(s): WO2006/084648

24 February 2011 Application Accepted

  Published as AU-B-2006212471

23 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006212473-Sample lysis and coating of reaction surface

2006212462-Helical conveyor without overdrive